Skip to main content

Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses

Publication ,  Journal Article
Martinino, A; Bucaro, A; Cardella, F; Wazir, I; Frongillo, F; Ardito, F; Giovinazzo, F
Published in: Frontiers in Oncology
January 1, 2024

Background: HCC is a major global health concern, necessitating effective treatment strategies. This study conducts a meta-analysis of meta-analyses comparing liver resection (LR) and liver transplantation (LT) for HCC. Methods: The systematic review included meta-analyses comparing liver resection vs. liver transplantation in HCC, following PRISMA guidelines. Primary outcomes included 5-year overall survival (OS) and disease-free survival (DFS). AMSTAR-2 assessed study quality. Citation matrix and hierarchical clustering validated the consistency of the included studies. Results: A search identified 10 meta-analyses for inclusion. The median Pearson correlation coefficient for citations was 0.59 (IQR 0.41-0.65). LT showed better 5-year survival and disease-free survival in all HCC (OR): 0.79; 95% CI: 0.67-0.93, I^2:57% and OR: 0.44; 95% CI: 0.25-0.75, I^2:96%). Five-year survival in early HCC and ITT was 0.63 (95% CI: 0.50-0.78, I^2:0%) and 0.60 (95% CI: 0.39-0.92, I^2:0%). Salvage LT vs. Primary LT did not differ between 5-year survival and disease-free survival (OR: 0.62; 95% CI: 0.33-1.15, I^2:0% and 0.93; 95% CI: 0.82-1.04, I^2:0%). Conclusion: Overall, the study underscores the superior survival outcomes associated with LT over LR in HCC treatment, supported by comprehensive meta-analysis and clustering analysis. There was no difference in survival or recurrence rate between salvage LT and primary LT. Therefore, considering the organ shortage, HCC can be resected and transplanted in case of recurrence.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Frontiers in Oncology

DOI

EISSN

2234-943X

Publication Date

January 1, 2024

Volume

14

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Martinino, A., Bucaro, A., Cardella, F., Wazir, I., Frongillo, F., Ardito, F., & Giovinazzo, F. (2024). Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1366607
Martinino, A., A. Bucaro, F. Cardella, I. Wazir, F. Frongillo, F. Ardito, and F. Giovinazzo. “Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses.” Frontiers in Oncology 14 (January 1, 2024). https://doi.org/10.3389/fonc.2024.1366607.
Martinino A, Bucaro A, Cardella F, Wazir I, Frongillo F, Ardito F, et al. Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses. Frontiers in Oncology. 2024 Jan 1;14.
Martinino, A., et al. “Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses.” Frontiers in Oncology, vol. 14, Jan. 2024. Scopus, doi:10.3389/fonc.2024.1366607.
Martinino A, Bucaro A, Cardella F, Wazir I, Frongillo F, Ardito F, Giovinazzo F. Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses. Frontiers in Oncology. 2024 Jan 1;14.

Published In

Frontiers in Oncology

DOI

EISSN

2234-943X

Publication Date

January 1, 2024

Volume

14

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis